Term Name: poziotinib
Synonyms: 1-(4-{[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy}piperidin-1-yl)prop-2-en-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one, HM 781-36B, HM-781-36B, HM781-36B, NOV 120101, NOV-1201, NOV-120101, NOV120101, poziotinib, poziotinibum
Definition: A member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, [1-(prop-2-enoyl)piperidin-4-yl]oxy, and methoxy groups at positions 4, 6, and 7, respectively. It is a potent and irreversible tyrosine kinase inhibitor targeting EGFR and HER2 with exon 20 insertion mutations.
Ontology: ChEBI [CHEBI:195559]  ( EBI )

Relationships
is a type of: acrylamides aromatic ether dichlorobenzene diether monofluorobenzenes N-acylpiperidine quinazolines secondary amino compound substituted aniline
has_role: antineoplastic agent apoptosis inducer epidermal growth factor receptor antagonist